Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature

doi:10.12998/wjcc.v6.i13.671

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6346)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

426

WORD

187

HTML

3144

Figures (1-1)

209

Sum=3966

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

941

Download

1439

Sum=2380

Nov 6, 2018 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Nov 6, 2018; 6(13): 671-674
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.671

Open in New Tab Full Size Figure Download Figure

Figure 1 Dynamic changes in biochemical parameters and hepatitis B virus DNA levels. LAM: Lamivudine; ADV: Adefovir dipivoxil; LDT: Telbivudine; TAF: Tenofovir alafenamide; TDF: Disoproxil fumarate; Cr: Creatinine; eGFR: Estimated glomerular filtration rate; ALT: Alanine aminotransferase; HCC: Hepatocellular carcinoma; CK: Creatine kinase.

Citation: Lu JC, Liu LG, Lin L, Zheng SQ, Xue Y. Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature. World J Clin Cases 2018; 6(13): 671-674
URL: https://www.wjgnet.com/2307-8960/full/v6/i13/671.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i13.671